Catherine Feore
banner
catherinefeore.bsky.social
Catherine Feore
@catherinefeore.bsky.social
Founder www.vitalsigns.news
Brussels-based journalist. working mostly on health - but occasionally other questions.
feorecatherine@gmail.com @HealthHubEditor on X
Vice President Association de la Presse Internationale @apibrussels over at x
What else is on the menu? The Bolar Exemption, data protection (a discussion that seems bound to also be addressed in review of GDPR) and security of supply.
November 11, 2025 at 10:04 AM
Courage!
November 5, 2025 at 12:15 AM
The Critical Medicine Act policy driver isn’t employment it is supply, Biotech Act more of an industrial policy act Rainer Becker DG SANTE.
November 4, 2025 at 9:35 AM
Pfizer's offer was $47.50 per Metsera share in cash upon closing, for an initial enterprise value of $4.9 billion with a CVR of up to $22.50 per share in additional payments. Novo $6.5B cash offer plus up to $2.5B in CVRs

www.pfizer.com/news/press-r...
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio | Pfizer
Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an init...
www.pfizer.com
October 30, 2025 at 10:40 AM
And this, this is what needs to be taught and with some degree of urgency.
October 22, 2025 at 6:23 AM